ArticleCanadian journal of gastroenterology = Journal canadien de gastroenterologie2013
The Second Canadian Symposium on hepatitis C virus: a call to action.
Article in Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Pilot postal birth cohort hepatitis C virus screening in UK primary care: HepCAPP study.The British journal of general practice : the journal of the Royal College of General Practitioners · 2025Article
- The 11th Canadian Symposium on Hepatitis C Virus: 'Getting back on track towards hepatitis C elimination'.Canadian liver journal · 2023Article
- The 9th Canadian Symposium on Hepatitis C Virus: Advances in HCV research and treatment towards elimination.Canadian liver journal · 2021Article
- The 8Canadian liver journal · 2020Article
- The 7th Canadian Symposium on Hepatitis C Virus: "Toward Elimination of HCV: How to Get There".Canadian liver journal · 2018Article
- The 5th Canadian Symposium on Hepatitis C Virus: We Are Not Done Yet-Remaining Challenges in Hepatitis C.Canadian journal of gastroenterology & hepatology · 2016Article
- Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan.Canadian journal of gastroenterology & hepatology · 2016Article
- Persons in correctional facilities in Canada: A key population for hepatitis C prevention and control.Canadian journal of public health = Revue canadienne de sante publique · 2015Article
- The undiagnosed chronically-infected HCV population in France. Implications for expanded testing recommendations in 2014.PloS one · 2015Article
- The 3rd Canadian Symposium on Hepatitis C Virus: expanding care in the interferon-free era.Canadian journal of gastroenterology & hepatology · 2014Article
- With all the new treatment regimens, complete elimination of hepatitis C virus in Canada is a possibility! But when will Canadians have access these drugs?Canadian journal of gastroenterology & hepatology · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
In Canada, hepatitis C virus (HCV) infection results in considerable morbidity, mortality and health-related costs. Within the next three to 10 years, it is expected that tolerable, short-duration (12 to 24 weeks) therapies capable of curing >90% of those who undergo treatment will be approved. Given that most of those already infected are aging and at risk for progressive liver disease, building research-based interdisciplinary prevention, care and treatment capacity is an urgent priority. In an effort to increase the dissemination of knowledge in Canada in this rapidly advancing field, the National CIHR Research Training Program in Hepatitis C (NCRTP-HepC) established an annual interdisciplinary Canadian Symposium on Hepatitis C Virus. The first symposium was held in Montreal, Quebec, in 2012, and the second symposium was held in Victoria, British Columbia, in 2013. The current article presents highlights from the 2013 meeting. It summarizes recent advances in HCV research in Canada and internationally, and presents the consensus of the meeting participants that Canada would benefit from having its own national HCV strategy to identify critical gaps in policies and programs to more effectively address the challenges of expanding HCV screening and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.